Elicera Therapeutics AB
STO:ELIC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elicera Therapeutics AB
STO:ELIC
|
SE |
|
T
|
Trencor Ltd
JSE:TRE
|
ZA |
|
P
|
Platform Turizm Tasimacilik Gida Insaat Temizlik Hizmetleri Sanayi ve Ticaret AS
IST:PLTUR.E
|
TR |
|
T
|
TVD Holdings PCL
SET:TVDH
|
TH |
|
Giocamondo Study SpA
MIL:GMS
|
IT |
|
Getty Realty Corp
F:GRL
|
US |
|
S
|
S Prime Growth Leasehold REIT
SET:SPRIME
|
TH |
|
Modulight Oyj
F:78W
|
FI |
|
Techtronic Industries Co Ltd
F:TIB1
|
HK |
|
L
|
Lantheus Holdings Inc
F:0L8
|
US |
|
Kansai Paint Co Ltd
OTC:KSANF
|
JP |
|
B
|
BW LPG Ltd
XMUN:BW9
|
SG |
|
Seco SpA
F:7GV
|
IT |
|
H
|
Hanwha Plus No 4 Special Purpose Acquisition Co
KOSDAQ:455310
|
KR |
|
AlphaGen Intelligence Corp
F:G4G
|
CA |
|
E
|
eBay Inc
BMV:EBAY
|
US |
|
Askari Metals Ltd
F:7ZG
|
AU |
Intrinsic Value
Is ELIC undervalued or overvalued?
See the intrinsic value estimate for Elicera Therapeutics AB and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ELIC looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ELIC’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Elicera Therapeutics AB Does
Elicera Therapeutics AB is a Swedish biotech company that develops cancer treatments based on the body’s immune system. Its work centers on two main drug types: oncolytic virus therapies that are meant to attack tumors and help trigger an immune response, and CAR T-cell therapies that engineer immune cells to recognize cancer more effectively.
- Headquarters
- Sweden SE
- IPO date
- Jun 11, 2021
Earnings Waterfall
Elicera Therapeutics AB
The intrinsic value for Elicera Therapeutics AB (ELIC) under the Base Case is hidden SEK.
Compared with the current market price of 2.99 SEK, the stock appears hidden.